Webpackaging logo

Aptar Pharma is bringing the respiratory world together

  • Aptar Pharma
Europe, Iberia, Portugal, Health, Pharmaceuticals, Product Development Services, Shows, Associations, Media

Aptar Pharma is pleased to announce the co-organization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, which will connect pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal, May 7-10, 2019.

Bringing the Respiratory World Together

Respiratory Drug Delivery Europe is a major conference bringing together experts from around the world to exchange emerging scientific knowledge and provide a dynamic forum for business networking. Approximately 500 delegates from 31 countries attended the 2017 edition in Antibes, France.

RDD Europe attracts high level academic, industrial and regulatory scientists, and clinicians. It is a must-attend conference for companies involved in the research, development, testing and marketing of medicines, devices and services associated with pulmonary or nasal products.

A premium, interactive three-day conference

This year, the conference will kick-off with a plenary lecture entitled “Emerging Treatment Guidelines in COPD: Unravelling the Triple Therapy Trials,” delivered by Jadwiga Wedzicha, M.D. Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London.

Subsequent sessions will focus on:

- New Approaches to Treating Old Diseases
- Pipes, Particles and Predictions: New Insights into Deposition
- Re-Inventing Inhalers for the Digital Age
- Take a Deep Breath: Brexit and Environmental Sustainability
- New Approaches to Inhalation Product Development and Production

As part of the conference, RDD Europe 2019 will underline innovative research contributions via both podium and scientific poster sessions. Scientific posters will highlight recent nasal and pulmonary pharmaceutical research, with five of the best posters showcased during “Posters on the Podium”, a fast-paced interactive session. All accepted graduate student poster abstracts are automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award.

RDD Europe 2019 will also host 12 workshops led by drug delivery device experts and service providers. Workshops are a unique opportunity for focused scientific and technical exchange on work-in-progress and hot topics. Delegates can choose from the selection of interactive technical workshops highlighting a variety of innovative technologies, products and services impacting the industry.

Valuable networking opportunities

RDD Europe 2019 offers numerous networking opportunities including the Technology Exhibition, where exhibitors display innovative technologies and services throughout the conference in RDD’s signature table-top format. Device and equipment designers, service providers, and consultants will be on hand to interact and share their knowledge.

A networking welcome cocktail reception will take place on the evening of May 7, and a Gala Dinner sponsored by Aptar Pharma will take place on Thursday, May 9 at a scenic location in Lisbon.

RDD Europe conferences have reached capacity in the past, so early registration is strongly recommended. The early bird rate will be available until January 21, 2019.

Further information about RDD Europe 2019, including the full program and registration details, is available at https://www.rddonline.com/rddeurope2019.

See also

Aptar acquires Nanopharm and Gateway Analytical, broadening pharma services platform to accelerate customer drug development

Aptar acquires Nanopharm and Gateway Analytical, broadening pharma services platform to accelerate customer drug development

AptarGroup, Inc. has announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.

Aptar Pharmas Freepod nasal spray device with GlaxoSmithKlines Otrivin wins prestigious WPO WorldStar 2019 award

Aptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 award

Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that its patented Freepod nasal spray device with GlaxoSmithKline's Otrivin has received a Medical & Pharma category award at the World Packaging Organization (WPO) 2019 WorldStar Packaging Awards ceremony, which took place on May 15, 2019 in Prague. The WorldStar Awards Competition, hosted by the WPO, is considered to be one of the most prestigious international packaging awards events.

Aptar Pharma launches PureHale, a new portable and ready-to-use upper respiratory drug delivery solution

Aptar Pharma launches PureHale, a new portable and ready-to-use upper respiratory drug delivery solution

Aptar Pharma, a leading drug delivery systems provider, continues its commitment to meeting new market trends with the release of an industry first, PureHale, a new portable and ready-to-use drug delivery solution designed for upper respiratory care. PureHale is a revolutionary and intuitive device which – when used in combination with saline or other natural ingredient formulations – helps relieve the symptoms of upper respiratory system conditions.

Join Aptar Pharmas live webinar Good medicine: Solutions for sensitive injectable formulations

Join Aptar Pharma's live webinar "Good medicine: Solutions for sensitive injectable formulations"

Aptar Pharma, a leading provider of innovative drug delivery systems, will host a live educational webinar presenting the benefits of high quality film coated elastomeric components and the role they play in reducing patient and regulatory risk. Taking place on October 24, 2018, at 15.00 GMT, the webinar, entitled “Good Medicine: Solutions for Sensitive Injectable Formulations” will demonstrate how high quality film coated components meet compliance expectations while maintaining safety of supply for the drug product..

New technologies in ophthalmic drug delivery webinar hosted by Aptar Pharma

New technologies in ophthalmic drug delivery webinar hosted by Aptar Pharma

Aptar Pharma, a leading provider of innovative drug delivery systems, has announced it will be hosting a live, complimentary webinar titled “Optimizing Patient Adherence and Compliance in Eye Care” on November 21 at 11AM EST. The webinar will offer expert insight from Matthias Birkhoff, Vice President Business Development at Aptar Pharma, and Dr. Degenhard Marx, Director Scientific Affairs within the Aptar Pharma Consumer Health Care Division.

Aptar Pharmas electronic lockout device approved by EMA

Aptar Pharma's electronic lockout device approved by EMA

Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approval by the European Medicines Agency (EMA) of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International AG. Aptar Pharma agreed to supply Takeda with its e-Lockout device for a multidose nasal spray version of Instanyl®. The EMA has granted marketing authorization for this multidose nasal spray treatment under the name Instanyl DoseGuardTM.

Aptar Pharmas preservative free multi-dose ophthalmic squeeze dispenser launches in the U.S.

Aptar Pharma's preservative free multi-dose ophthalmic squeeze dispenser launches in the U.S.

Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, has partnered with a leading eye care company to develop and launch a new eye drop product, which uses Aptar Pharma's innovative preservative free multi-dose Ophthalmic Squeeze Dispenser (OSD). This is the first preservative free multi-dose eye drop featuring Aptar Pharma's OSD in the United States.

The tenth anniversary of RDD Europe: A great success for the international Respiratory Drug Delivery community

The tenth anniversary of RDD Europe: A great success for the international Respiratory Drug Delivery community

RDD® Europe 2015 hosted 450 pulmonary and nasal drug delivery experts from 31 countries at its latest conference in Antibes, France, demonstrating once again that it is the "must attend" European event in pulmonary and nasal drug delivery. RDD Europe is a prestigious event, jointly organized by RDD Online and Aptar Pharma, bringing together scientists, clinicians, business professionals and regulators to further research, development, clinical evaluation and marketing of current and new drugs delivered through the lungs or nose.

  • Company News
  • English
  • Modified 15 Jan 2019
  • Hits 389